Effects of Oral Alendronate on BMD in Adult Patients With Osteogenesis Imperfecta: A 3-Year Randomized Placebo-Controlled Trial
Open Access
- 1 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (2) , 300-306
- https://doi.org/10.1359/jbmr.051015
Abstract
A 3‐year, randomized, double‐blind, placebo‐controlled trial evaluated the effect of oral alendronate on the BMD of 64 adult patients with osteogenesis imperfecta. The mean increases in the lumbar sp...Keywords
This publication has 22 references indexed in Scilit:
- Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapyBone, 2004
- Intravenous Neridronate in Adults With Osteogenesis ImperfectaJournal of Bone and Mineral Research, 2003
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Alendronate for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisNew England Journal of Medicine, 1998
- Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosisJournal of Bone and Mineral Research, 1996
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Osteogenesis Imperfecta after the MenopauseNew England Journal of Medicine, 1984
- 10 Genetic and Environmental F actors in the Etiology of Congenital Dislocation of the HipPublished by Wolters Kluwer Health ,1964